Meta AnalysisID 714

色氨酸-犬尿氨酸通路在母体、胎儿及胎盘健康与妊娠结局中的作用:一项系统评价

CRD42021273120

What is the role of the tryptophan and kynurenine pathway in maternal, foetal and placental health, and pregnancy outcome?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
714
Evidence Id
9272
Core Evidence Id
9272
Source Meta Analysis Id
704
Herb2 Meta Analysis Id
HBMA000704
Crd Id
CRD42021273120
Title
The role of the tryptophan and kynurenine pathway in maternal, foetal and placental health, and pregnancy outcome: a systematic review
Review Question
What is the role of the tryptophan and kynurenine pathway in maternal, foetal and placental health, and pregnancy outcome?
Study Type Included
We will include human experimental (e.g. randomised controlled trials, in vivo, in vitro and ex vivo studies) and observational studies (e.g. cohort studies, case-control studies and cross-sectional studies). In contrast, we will exclude animal studies, case reports, case series, conference abstracts, letters, editorials, opinion papers and reviews. However, we will use animal studies in the introduction and in the discussion to substantiate our results. In addition, we will screen the reference lists of reviews for additional eligible studies previously missed by the search.
Condition Being Studied
Pregnant women without any restriction regarding study setting (such as first-line and tertiary care treatment).
Participant
Inclusion: Pregnant women. Exclusion: Non-pregnant women.
Animal
Human Disease Modelled
Intervention
We will focus on metabolites involved in the tryptophan and kynurenine pathway, such as: 1) Tryptophan 2) N-formyl kynurenine 3) Kynurenine 4) Kynurenic acid 5) 3-Hydroxykynurenine 6) Xanthurenic acid 7) 3-Hydroxyanthranilic acid (3-HAA) 8) α-amino-β-carboxymuconate-ε-semialdehyde (ACMS) 9) Quinolinic acid 10) Picolinic acid 11) 3-Hydroxyanthranilic acid 12) Nicotinamide-Adenine-Dinucleotide (NAD+)
Comparator Control
As there are no clinical cut off points, we will focus on differences in levels of metabolites involved in the tryptophan and kynurenine pathway and on different responses to metabolites involved in the tryptophan and kynurenine pathway.
Main Outcome
1) Foetal health: e.g. embryonic and foetal growth and development 2) Maternal health: pregnancy complications such as pregnancy induced hypertensive disorders (e.g. preeclampsia) and gestational diabetes 3) Placental health: e.g. placental (in)sufficiency, weight, (mal)perfusion, vascular function and oxidative damage 4) Pregnancy outcome: e.g. miscarriages, preterm birth, small for gestational age (SGA), low birthweight and congenital malformations Measures of effect Depending on the study design and the measured exposures and outcomes, we will report betas, mean differences, relative risks and odds ratios.
Outcome Measure
Additional Outcome
None. Measures of effect
Study Method
Systematic review
Keyword
Female; Humans; Kynurenine; Placenta; Pregnancy; Pregnancy Outcome; Tryptophan
Contact
Sofie van Zundert [email protected]
Organisational Affiliation
Erasmus MC, University Medical Centre, Rotterdam, the Netherlands www.erasmusmc.nl
Funding Source
Erasmus MC, University Medical Centre, Rotterdam, the Netherlands
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Netherlands
Review Stage
Review Ongoing
First Submission Date
2021-08-11
Registration Date
2021-09-11
Anticipated Start Date
2021-05-10
Anticipated Completion Date
2021-12-10
Title Cn
色氨酸-犬尿氨酸通路在母体、胎儿及胎盘健康与妊娠结局中的作用:一项系统评价
Title En
The role of the tryptophan and kynurenine pathway in maternal, foetal and placental health, and pregnancy outcome: a systematic review
Bilingual Status
complete